Valhalla Ventures — 2024 Investments
4 investments dated 2024 · listed companies and verified rows first · show all
Burlingame, US
MIHIR VIJAY GONDHALEKAR(Director)Saurav Shroff(Founder)in
Board seatRohan Pujara· per SEC Form D
Co-investorsBalerion Space VenturesCrucible CapitalFusionGoAhead VenturesHummingbird Ventures8VC+3 more
Arda develops therapeutics using single-cell computational biology to target and eliminate pathogenic cells in chronic diseases.
AI & Machine LearningBiotechMedical DevicesAustin, US
Adam Freund(Founder & Chief Executive Officer)inRemi-Martin Laberge(Founder and Chief Technology Officer)in
BoardVineeta Agarwala(Director)in
Co-investorsage1Andreessen HorowitzStrawberry Creek VenturesAlumni VenturesGaingelsGV (Google Ventures)+3 more
__Twitter.png)
Arda Therapeutics is a drug development company that uses single-cell computational biology to identify and eliminate pathogenic cells as a way to treat chronic diseases.
AI & Machine LearningBiotechDigital HealthLongevityMedical Devices
Adam Freund(Founder & Chief Executive Officer)inRemi-Martin Laberge(Founder & Chief Technology Officer)in
Co-investorsGV (Google Ventures)Alumni VenturesAxial VCGaingelsIndicator VenturesMana Ventures+1 more
Co-investorsAurum Venture PartnersDraper AssociatesRed Beard VenturesService Provider CapitalVU Venture Partners
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.